These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9562970)

  • 1. 11q13 allelotype analysis in 27 northern American MEN1 kindreds identifies two distinct founder chromosomes.
    Emmert-Buck MR; Debelenko LV; Agarwal S; Kester MB; Manickam P; Zhuang Z; Guru SC; Olufemi SE; Burns AL; Chandrasekharappa SC; Lubensky IA; Liotta LA; Skarulis MC; Spiegel AM; Marx SJ; Collins FS
    Mol Genet Metab; 1998 Feb; 63(2):151-5. PubMed ID: 9562970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland.
    Olufemi SE; Green JS; Manickam P; Guru SC; Agarwal SK; Kester MB; Dong Q; Burns AL; Spiegel AM; Marx SJ; Collins FS; Chandrasekharappa SC
    Hum Mutat; 1998; 11(4):264-9. PubMed ID: 9554741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene.
    Debelenko LV; Emmert-Buck MR; Manickam P; Kester M; Guru SC; DiFranco EM; Olufemi SE; Agarwal S; Lubensky IA; Zhuang Z; Burns AL; Spiegel AM; Liotta LA; Collins FS; Marx SJ; Chandrasekharappa SC
    Cancer Res; 1997 Mar; 57(6):1039-42. PubMed ID: 9067266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families.
    Agarwal SK; Debelenko LV; Kester MB; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Heppner C; Crabtree JS; Lubensky IA; Zhuang Z; Kim YS; Chandrasekharappa SC; Collins FS; Liotta LA; Spiegel AM; Burns AL; Emmert-Buck MR; Marx SJ
    Hum Mutat; 1998; 12(2):75-82. PubMed ID: 9671267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.
    Emmert-Buck MR; Lubensky IA; Dong Q; Manickam P; Guru SC; Kester MB; Olufemi SE; Agarwal S; Burns AL; Spiegel AM; Collins FS; Marx SJ; Zhuang Z; Liotta LA; Chandrasekharappa SC; Debelenko LV
    Cancer Res; 1997 May; 57(10):1855-8. PubMed ID: 9157974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
    Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
    Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated familial somatotropinomas: clinical and genetic considerations.
    Frohman LA
    Trans Am Clin Climatol Assoc; 2003; 114():165-77. PubMed ID: 12813918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours.
    Farrell WE; Simpson DJ; Bicknell J; Magnay JL; Kyrodimou E; Thakker RV; Clayton RN
    Br J Cancer; 1999 Apr; 80(1-2):44-50. PubMed ID: 10389976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1).
    Courseaux A; Grosgeorge J; Gaudray P; Pannett AA; Forbes SA; Williamson C; Bassett D; Thakker RV; Teh BT; Farnebo F; Shepherd J; Skogseid B; Larsson C; Giraud S; Zhang CX; Salandre J; Calender A
    Genomics; 1996 Nov; 37(3):354-65. PubMed ID: 8938448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
    Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B
    Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region.
    Manickam P; Guru SC; Debelenko LV; Agarwal SK; Olufemi SE; Weisemann JM; Boguski MS; Crabtree JS; Wang Y; Roe BA; Lubensky IA; Zhuang Z; Kester MB; Burns AL; Spiegel AM; Marx SJ; Liotta LA; Emmert-Buck MR; Collins FS; Chandrasekharappa SC
    Hum Genet; 1997 Nov; 101(1):102-8. PubMed ID: 9385379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
    Pourani J; Kaserer K; Pfragner R
    Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline mutations in the multiple endocrine neoplasia type 1 gene: evidence for frequent splicing defects.
    Mutch MG; Dilley WG; Sanjurjo F; DeBenedetti MK; Doherty GM; Wells SA; Goodfellow PJ; Lairmore TC
    Hum Mutat; 1999; 13(3):175-85. PubMed ID: 10090472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.
    Larsson C; Shepherd J; Nakamura Y; Blomberg C; Weber G; Werelius B; Hayward N; Teh B; Tokino T; Seizinger B
    J Clin Invest; 1992 Apr; 89(4):1344-9. PubMed ID: 1348254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clouston hidrotic ectodermal dysplasia (HED): genetic homogeneity, presence of a founder effect in the French Canadian population and fine genetic mapping.
    Kibar Z; Dubé MP; Powell J; McCuaïg C; Hayflick SJ; Zonana J; Hovnanian A; Radhakrishna U; Antonarakis SE; Benohanian A; Sheeran AD; Stephan ML; Gosselin R; Kelsell DP; Christianson AL; Fraser FC; Der Kaloustian VM; Rouleau GA
    Eur J Hum Genet; 2000 May; 8(5):372-80. PubMed ID: 10854098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.
    Vortmeyer AO; Lubensky IA; Skarulis M; Li G; Moon YW; Park WS; Weil R; Barlow C; Spiegel AM; Marx SJ; Zhuang Z
    Mod Pathol; 1999 Sep; 12(9):919-24. PubMed ID: 10496602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic carnitine palmitoyl transferase 1 (CPT1 A) deficiency in North American Hutterites (Canadian and American): evidence for a founder effect and results of a pilot study on a DNA-based newborn screening program.
    Prasad C; Johnson JP; Bonnefont JP; Dilling LA; Innes AM; Haworth JC; Beischel L; Thuillier L; Prip-Buus C; Singal R; Thompson JR; Prasad AN; Buist N; Greenberg CR
    Mol Genet Metab; 2001 May; 73(1):55-63. PubMed ID: 11350183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The European Consortium on MEN1. Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN1).
    Hum Genet; 1997 Oct; 100(5-6):657-65. PubMed ID: 9341888
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12.
    Gadelha MR; Une KN; Rohde K; Vaisman M; Kineman RD; Frohman LA
    J Clin Endocrinol Metab; 2000 Feb; 85(2):707-14. PubMed ID: 10690880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.